It had been verified in ApoE (−/−) mice that the over expression of DCN could reduce inflammation in atherosclerotic plaques, thereby decelerating the progression of atherosclerosis (Al Haj Zen et al., 2006). The gene discussed is DCN; the disease is atherosclerosis.